Sarissa Capital Management’s Regulus Therapeutics RGLS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-185,183	Closed	-$291K	–	10
2024 Q3	$291K	Hold	185,183	–	–	0.07%	10
2024 Q2	$331K	Hold	185,183	–	–	0.06%	10
2024 Q1	$533K	Hold	185,183	–	–	0.09%	10
2023 Q4	$237K	Hold	185,183	–	–	0.04%	9
2023 Q3	$254K	Hold	185,183	–	–	0.03%	11
2023 Q2	$272K	Hold	185,183	–	–	0.03%	11
2023 Q1	$157K	Hold	185,183	–	–	0.02%	10
2022 Q4	$254K	Hold	185,183	–	–	0.03%	11
2022 Q3	$315K	Hold	185,183	–	–	0.04%	11
2022 Q2	$383K	Sell	185,183 -1,666,668	-90%	-$3.45M	0.04%	11
2022 Q1	$552K	Hold	1,851,851	–	–	0.05%	11
2021 Q4	$583K	Hold	1,851,851	–	–	0.05%	11
2021 Q3	$1.28M	Hold	1,851,851	–	–	0.1%	10
2021 Q2	$1.51M	Hold	1,851,851	–	–	0.12%	11
2021 Q1	$2.89M	Hold	1,851,851	–	–	0.28%	11
2020 Q4	$2.5M	Hold	1,851,851	–	–	0.26%	10
2020 Q3	$951K	Hold	1,851,851	–	–	0.11%	10
2020 Q2	$1.26M	Hold	1,851,851	–	–	0.14%	11
2020 Q1	$853K	Hold	1,851,851	–	–	0.11%	10
2019 Q4	$1.65M	Hold	1,851,851	–	–	0.14%	11
2019 Q3	$1.33M	Hold	1,851,851	–	–	0.17%	10
2019 Q2	$2.31M	Buy	+1,851,851	New	+$2.31M	0.29%	11